Overview

Pilot Trial for Implementation of a MPA PK Monitoring Strategy

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study is a prospective interventional trial of de novo renal transplant recipients, aiming to validate a strategy which combines the use of early post transplant MPA AUC sampling, and subsequent MPA trough level monitoring to implement MPA PK monitoring in a clinically applicable fashion.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Florida
Collaborator:
Hoffmann-La Roche
Treatments:
Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus
Criteria
Inclusion Criteria:

- primary or secondary cadaveric or living donor kidney recipients

- On Cellcept

Exclusion Criteria:

- Multi organ recipients

- Documented non-compliance

- Not on a calcineurin inhibitor

- GFR <25 ml/min by Cockcroft Gault equation

- Serum albumin <2.5 mg/dl

- Pregnant

- Active serious digestive disorder